Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2005
09/15/2005US20050201959 Administering a cytokine in conjunction a therapeutic procedure to remove a tattoo
09/15/2005US20050201951 Inhalation of alpha one-antitrypsin (AAT); emphysema; cigarettes and kits comprising AAT
09/15/2005US20050201950 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
09/15/2005US20050201939 Dye-peptide complex; supplying to tumor cells; for diagnostic imaging and therapy; biocompatibility
09/15/2005US20050201938 Method for selectively inhibiting ghrelin action
09/15/2005US20050201932 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms
09/15/2005US20050201931 LAT1 transporters expressed in blood brain barrier cells
09/15/2005US20050199498 Electrophoresis; fibrinogen
09/15/2005CA2820541A1 Caspase inhibitors and uses thereof
09/15/2005CA2812132A1 Natural igm antibodies and inhibitors thereof
09/15/2005CA2563397A1 Adzymes and uses thereof
09/15/2005CA2559958A1 A differentiation- or regeneration-inducing agent for alveoli
09/15/2005CA2559067A1 Influenza virus infection suppressor
09/15/2005CA2558721A1 Screening method for emulators of neural activity and digestive system using gpr35
09/15/2005CA2558660A1 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
09/15/2005CA2558655A1 Methods and compositions for treatment of autoimmune diseases
09/15/2005CA2558497A1 Use of a mixture for the production of an agent for treating defective or degenerated cartilage in the production of natural cartilage replacement in vitro
09/15/2005CA2558478A1 Alk7 and myostatin inhibitors and uses thereof
09/15/2005CA2558416A1 Use of lipid conjugates in the treatment of disease
09/15/2005CA2558399A1 Partially loaded antibodies and methods of their conjugation
09/15/2005CA2558380A1 Combination therapy with glatiramer acetate and riluzole
09/15/2005CA2558379A1 Multi-component biological transport systems
09/15/2005CA2558263A1 Nanocell drug delivery system
09/15/2005CA2558183A1 Use of enhanced water to improve blood sugar management
09/15/2005CA2557976A1 Use of antagonists of the cb1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
09/15/2005CA2557876A1 Powdered compositions of sensitive active materials in an at least partially amorphous state
09/15/2005CA2557814A1 Compositions and methods for treating diseases
09/15/2005CA2557788A1 Mutein of a bone morphogenetic protein and use thereof
09/15/2005CA2557654A1 Peptides of il1 beta and tnf alpha and method of treatment using same
09/15/2005CA2557645A1 Caspase inhibitors and uses thereof
09/15/2005CA2557610A1 Use of carboxypeptidase g for combating antifolate toxicity
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005CA2557304A1 Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005CA2556339A1 Interferon-beta polymer conjugates
09/15/2005CA2555612A1 Compositions and methods for the treatment and clinical remission of psoriasis
09/15/2005CA2529752A1 Polypeptide transduction and fusogenic peptides
09/14/2005EP1574579A2 Outer surface proteins, their genes, and their use
09/14/2005EP1574578A1 Monomeric protein of the TGF-beta family
09/14/2005EP1574577A2 Growth differentiation factor-11
09/14/2005EP1574575A1 GLUCOSE AND/OR FRUCTOSE TRANSPORTER NaGLT1 AND ITS GENE
09/14/2005EP1574520A2 Methods and materials relating to neuronal guidance molecule-like (NGM-like) polypeptides and polynucleotides
09/14/2005EP1574519A1 Transcription control factor ZHX3
09/14/2005EP1574518A2 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
09/14/2005EP1574516A1 Antithrombotic compound
09/14/2005EP1574219A2 Method of inhibiting fibrosis with a somatostatin agonist
09/14/2005EP1574211A1 Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
09/14/2005EP1574209A1 Device and method for treating ophthalmic diseases
09/14/2005EP1573333A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)
09/14/2005EP1573332A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3)
09/14/2005EP1573331A1 Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
09/14/2005EP1573070A2 pRNA CHIMERA
09/14/2005EP1573063A2 Treatment of liver deseases
09/14/2005EP1573047A2 Lectin compositions and methods for modulating an immune response to an antigen
09/14/2005EP1573046A2 Protease resistant ti-growth hormone releasing hormone
09/14/2005EP1573045A2 Heart failure gene determination and therapeutic screening
09/14/2005EP1573039A2 Compositions and methods for diagnosing and treating mood disorders
09/14/2005EP1573030A2 Irak-m is a negative regulator of toll-like receptor signaling
09/14/2005EP1573029A2 Modulation of immune-cell related disorders using il-1hy2
09/14/2005EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
09/14/2005EP1573026A2 Mre11: modulation of cellular proliferation
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
09/14/2005EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
09/14/2005EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
09/14/2005EP1573021A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
09/14/2005EP1573011A1 Method for preparing recombinant heterocarpine
09/14/2005EP1573005A2 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572987A2 Novel nucleic acids and polypeptides
09/14/2005EP1572970A2 Inhibitory oliogonucleotides targeted to bcl-2
09/14/2005EP1572968A2 Lutzomyia longipalpis polypeptides and methods of use
09/14/2005EP1572967A2 Il-1 receptor based antagonists and methods of making and using
09/14/2005EP1572963A2 Carbohydrate-based synthetic vaccines for hiv
09/14/2005EP1572961A2 Actriib fusion polypeptides and uses therefor
09/14/2005EP1572960A2 Identification of a novel bitter taste receptor, t2r76
09/14/2005EP1572957A2 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
09/14/2005EP1572956A2 Methods and kits for synthesis of sirna expression cassettes
09/14/2005EP1572953A2 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42
09/14/2005EP1572952A2 Novel polynucleotide and polypeptide sequences and uses thereof
09/14/2005EP1572951A2 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation
09/14/2005EP1572944A2 Methods and compositions for modulating xbp-1 activity
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572936A2 Heterologous g-csf fusion proteins
09/14/2005EP1572934A2 Follistatin domain containing proteins
09/14/2005EP1572933A2 Modulation of immune response by non-peptide binding stress response polypeptides
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572926A2 Polynucleotide encoding a novel cysteine protease of the calpain superfamily, protease-42
09/14/2005EP1572924A2 Contraceptive targets
09/14/2005EP1572919A2 Methods and compositions for use in homologous recombination
09/14/2005EP1572915A2 Preservation of bioactive materials by spray drying
09/14/2005EP1572909A2 A follistatin domain containing protein
09/14/2005EP1572908A2 Chimeric molecules for cleavage in a treated host
09/14/2005EP1572907A2 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same
09/14/2005EP1572906A2 Novel nucleic acid molecules and polypeptides encoding baboon tafi
09/14/2005EP1572905A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572898A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572894A2 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto
09/14/2005EP1572892A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
09/14/2005EP1572891A2 Bone anti-resorptive compounds
09/14/2005EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use
1 ... 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 ... 3163